NuScale Power Shares Plunge 75% This Year on Customer Deal Uncertainty, Dilution Fears
NuScale Power's stock has plunged 75% from its mid-year peak, including a 30% drop in December, as it still lacks a binding customer contract for its NRC-certified SMR design. It posted a $532 million loss and won approval to boost authorized shares from 332 million to 662 million, intensifying dilution concerns.
1. First-Mover Advantage and Regulatory Milestone
NuScale Power is the only U.S. developer to secure Nuclear Regulatory Commission design certification for its small modular reactor (SMR), a milestone achieved in August 2023 after nearly a decade of design reviews and safety validations. This approval positions the company to lead the nascent SMR market, with its 77-megawatt modules engineered for incremental capacity additions and passive safety features that require no active cooling systems. The design certification also paves the way for accelerated licensing at customer sites and potential export opportunities to markets seeking carbon-free baseload generation.
2. Customer Pipeline and Contract Uncertainty
Despite its regulatory edge, NuScale has yet to finalize a binding contract for its first commercial deployment. The Romanian utility RoPower has signaled intent to procure 12 SMR modules for a 924-megawatt plant under a memorandum of understanding, but negotiations remain incomplete and no purchase orders have been issued. Domestically, the Tennessee Valley Authority’s ENTRA1 Energy joint venture has explored a site in eastern Tennessee, with an initial proposal for up to six modules, yet has not committed funding. Investors are watching these two pipeline opportunities closely, as the signing of a binding engineering, procurement and construction agreement would validate NuScale’s business model and trigger downstream revenue recognition.
3. Financial Burn Rate and Shareholder Authorization
NuScale reported a net loss of $532 million for the third quarter, driven by ongoing R&D expenditures and staffing for reactor licensing support. Cash and equivalents stood at $754 million at quarter-end, bolstered by proceeds from a 13.2-million-share secondary offering earlier in the year. In December, shareholders approved an increase in authorized common shares from 332 million to 662 million, providing flexibility for future capital raises but raising dilution concerns. Management estimates that current cash reserves will fund operations into mid-2026, contingent on continued federal cost-share funding and the timing of any customer deposits.
4. Key Investor Indicators
Analysts highlight three critical metrics to assess NuScale’s near-term viability: the execution timeline for RoPower’s front-end engineering and design contract; the award of a site construction license by the NRC for any customer-specific project; and the pace of DOE cost-share reimbursements, which total $218 million to date under the Civil Nuclear Credit program. Progress on these fronts would signal de-risking of the company’s roadmap from design to revenue, whereas further delays could extend the cash-burn runway and exacerbate dilution risk for existing shareholders.